HIV-2 in the United Kingdom--a review. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


HIV-2 in the United Kingdom--a review.

CDR (Lond Engl Rev). 1991 Feb 1;1(2):R19-23. Unique Identifier : AIDSLINE MED/94138440
Evans BG; Gill ON; Gleave SR; Mortimer PP; Parry JV


Abstract: Human immunodeficiency virus type 2 (HIV-2) was first recognised in 1986 and subsequently the infection was shown to be widespread in West Africa. There have been few case reports from countries outside the African continent. In North America and Europe the highest number of infections have been in Portugal and France. Twelve HIV-2 infections have been identified in the United Kingdom (UK) and nine of the twelve had some connection with Africa, mostly West Africa; in three cases only sub-Saharan Africa was stated on the report, and one was from Mozambique. The other three HIV-2 infections were identified as follows: one in stored sera from a man who died in 1978, one in a child from Portugal who was diagnosed in the UK as having Acquired Immune Deficiency Syndrome (AIDS) in 1985, and one in a homosexual man who was tested unlinked and anonymously in London in 1987. It is not known how many of the total number of UK HIV-2 infections are represented by these twelve, but among large numbers of blood donors and people attending genitourinary medicine clinics the occurrence of infection was rare.
Keywords: Adult AIDS Serodiagnosis Child Contact Tracing Cross-Sectional Studies Female Great Britain/EPIDEMIOLOGY Human HIV Infections/*EPIDEMIOLOGY/TRANSMISSION *HIV-2 Incidence Male Travel JOURNAL ARTICLE REVIEW REVIEW, TUTORIALKWDadultaidsserodiagnosischildcontacttracingcross-sectionalstudiesfemalegreatbritain/epidemiologyhumanhivinfections/KWDepidemiology/transmissionKWDhiv-2incidencemaletraveljournalarticlereviewreview,tutorial
940530
M9450875

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .